BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7000494)

  • 1. Gastric inhibitory polypeptide and insulin: response to intraduodenal and intravenous glucose infusions in fetal and neonatal pigs.
    Kühl C; Hornnes PJ; Jensen SL; Lauritsen KB
    Endocrinology; 1980 Nov; 107(5):1446-50. PubMed ID: 7000494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intraduodenal and intravenous triglyceride infusions on plasma gastric inhibitory polypeptide and insulin in fetal and neonatal pigs.
    Kühl C; Hornnes PJ; Jensen SL; Lauritsen KB
    Diabetologia; 1982 Jul; 23(1):41-4. PubMed ID: 6749583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
    Lauritsen KB; Moody AJ
    Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ; Miller LJ; Service FJ; Go VL
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
    Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
    Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of total parenteral nutrition (TPN) on the enteroinsular axis in the rat.
    Pederson RA; Innis SM; Buchan AM; Chan CB; Brown JC
    Regul Pept; 1985 Mar; 10(2-3):199-206. PubMed ID: 3922014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepant performance on oral and intravenous glucose tolerance tests: the role of gastric inhibitory polypeptide.
    Elahi D; Andersen DK; Tobin JD; Andres R
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1199-203. PubMed ID: 7014599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
    Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
    Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease.
    Lauritsen KB; Lauritzen JB; Christensen KC
    Scand J Gastroenterol; 1982 Mar; 17(2):241-5. PubMed ID: 6753103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-dependent insulinotropic polypeptide (GIP) and the enteroinsular axis in equines (Equus caballus).
    Dühlmeier R; Deegen E; Fuhrmann H; Widdel A; Sallmann HP
    Comp Biochem Physiol A Mol Integr Physiol; 2001 Jun; 129(2-3):563-75. PubMed ID: 11423326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between plasma GIP and insulin after oral glucose.
    Lauritsen KB; Moody AJ
    Scand J Gastroenterol; 1980; 15(8):953-7. PubMed ID: 7015475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-induced GIP levels in patients with insulinoma.
    Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
    Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of gastric inhibitory polypeptide (GIP) and the effect of intraduodenal acidification on glucose-stimulated and unstimulated GIP release in humans.
    Flaten O
    Scand J Gastroenterol; 1981; 16(4):545-54. PubMed ID: 7034154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric inhibitory polypeptide and hyperinsulinemia in the Zucker (fa/fa) rat: a developmental study.
    Chan CB; Pederson RA; Buchan AM; Tubesing KB; Brown JC
    Int J Obes; 1985; 9(2):137-46. PubMed ID: 3897081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the enteroinsular axis in two strains of obese rat, the fatty Zucker and the JCR:LA-corpulent.
    Pederson RA; Campos RV; Buchan AM; Chisholm CB; Russell JC; Brown JC
    Int J Obes; 1991 Jul; 15(7):461-70. PubMed ID: 1894423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
    Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion.
    Thomas FB; Mazzaferri EL; Crockett SE; Mekhjian HS; Gruemer HD; Cataland S
    Gastroenterology; 1976 Apr; 70(4):523-7. PubMed ID: 815125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man.
    Lucey MR; Fairclough PD; Wass JA; Kwasowski P; Medbak S; Webb J; Rees LH
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):209-17. PubMed ID: 6148162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of synthetic human glucose-dependent insulinotropic polypeptide (hGIP) on the release of insulin in man.
    Füessl HS; Yiangou Y; Ghatei MA; Goebel FD; Bloom SR
    Eur J Clin Invest; 1990 Oct; 20(5):525-9. PubMed ID: 2124984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal enteroinsular axis in newborn infants of insulin-treated diabetic mothers.
    Knip M; Kääpä P; Koivisto M
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1340-4. PubMed ID: 8077330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.